Last reviewed · How we verify
Cooled Sodium Chloride Injection
At a glance
| Generic name | Cooled Sodium Chloride Injection |
|---|---|
| Sponsor | West Virginia University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Analysis of Safety and Tissue Interaction of Injectable and Energy-based Biosmulators (NA)
- Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride (PHASE1, PHASE2)
- UCB Stem Cells for Autism Spectrum Disorders (PHASE1)
- Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cooled Sodium Chloride Injection CI brief — competitive landscape report
- Cooled Sodium Chloride Injection updates RSS · CI watch RSS
- West Virginia University portfolio CI